Antibiotics in the treatment of tonsillar disease

Abstract

Tonsillar disease is one of the most common pathologies worldwide. People of all ages are at risk of the disease; however, inflammatory tonsillar diseases in children are especially challenging due to the risk of severe complications. Despite the fact that treatment algorithms for tonsillar disease are described in various global and national guidelines, the adequate choice of antimicrobial agents often causes difficulties for practitioners.